newsfilter
← Latest News
PR Newswire·

Provention Bio Announces Update to Board of Directors

RED BANK, N.J., June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced Dr. Jeffrey Bluestone's decision to step down as a director on